RJA
ABAX

Raymond James & Associates’s Abaxis Inc ABAX Stock Holding History

Raymond James & Associates’s Portfolio ABAX Stock Details ABAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-126,600
Closed -$10.5M – 3818
2018
Q2 		$10.5M Buy
126,600
+2,010
+2% +$154K 0.02% 785
2018
Q1 		$8.8M Buy
124,590
+1,668
+1% +$112K 0.02% 849
2017
Q4 		$6.09M Buy
122,922
+9,111
+8% +$435K 0.01% 1026
2017
Q3 		$5.08M Buy
113,811
+5,642
+5% +$268K 0.01% 1070
2017
Q2 		$5.74M Buy
108,169
+8,933
+9% +$439K 0.01% 976
2017
Q1 		$4.81M Buy
99,236
+994
+1% +$49.3K 0.01% 1034
2016
Q4 		$5.18M Buy
98,242
+1,019
+1% +$52.5K 0.01% 974
2016
Q3 		$5.02M Buy
97,223
+24,435
+34% +$1.22M 0.01% 946
2016
Q2 		$3.44M Buy
72,788
+27,684
+61% +$1.25M 0.01% 1048
2016
Q1 		$2.05M Buy
45,104
+9,743
+28% +$433K 0.01% 1266
2015
Q4 		$1.97M Buy
+35,361
New +$1.79M 0.01% 1274

Raymond James & Associates's ABAX Position: Q3 2018 in Review

Raymond James & Associates sold out of Abaxis Inc (ABAX) in Q3 2018, closing a stake of 126,600 shares — an estimated $10.5M sold.

Raymond James & Associates first reported a position in ABAX in Q4 2015 and held it in 11 quarters. The position peaked at $10.5M in Q2 2018. 0 funds tracked by Wall St. Rank hold ABAX as of Q3 2018.

  • Raymond James & Associates reported no remaining Abaxis Inc position as of Q3 2018 after selling out during the quarter.
  • Raymond James & Associates sold 126,600 Abaxis Inc shares in Q3 2018, an estimated $10.5M.
  • Raymond James & Associates first reported a position in Abaxis Inc in Q4 2015 and held it in 11 quarters.
  • Raymond James & Associates's Abaxis Inc position peaked at $10.5M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Abaxis Inc as of Q3 2018.

Based on Raymond James & Associates's 13F filing for Q3 2018, filed 14 Nov 2018.